Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126612352 | 12661235 | 2 | F | 20160507 | 20160512 | 20160817 | 20160901 | EXP | US-RELYPSA-RLY2016000709 | RELYPSA | 70.22 | YR | F | Y | 0.00000 | 20160901 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126612352 | 12661235 | 1 | PS | VELTASSA | PATIROMER | 1 | Oral | 8.4 G, QD | 16.7999992 | G | Y | VPST | 0 | 8.4 | G | ORAL SUSPENSION | |||
126612352 | 12661235 | 2 | SS | KEFLEX | CEPHALEXIN | 1 | Unknown | UNK | Y | 0 | |||||||||
126612352 | 12661235 | 3 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 4 MG, UNKNOWN | 0 | 4 | MG | |||||||||
126612352 | 12661235 | 4 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
126612352 | 12661235 | 5 | C | ZETIA | EZETIMIBE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
126612352 | 12661235 | 7 | C | BUSPAR | BUSPIRONE HYDROCHLORIDE | 1 | 1 AT NIGHT | 0 | |||||||||||
126612352 | 12661235 | 8 | C | XANAX | ALPRAZOLAM | 1 | 1 AT NIGHT | 0 | |||||||||||
126612352 | 12661235 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
126612352 | 12661235 | 10 | C | CLONIDINE. | CLONIDINE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 11 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 12 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 13 | C | AMBIEN CR | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 14 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 15 | C | PROTONIX /00661201/ | OMEPRAZOLE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 16 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 0 | ||||||||||||
126612352 | 12661235 | 17 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK, UNK, QD | 0 | |||||||||||
126612352 | 12661235 | 18 | C | CO Q 10 /00517201/ | 2 | 0 | |||||||||||||
126612352 | 12661235 | 19 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
126612352 | 12661235 | 20 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 1/2 TABLET, DAILY | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126612352 | 12661235 | 1 | Hyperkalaemia |
126612352 | 12661235 | 2 | Localised infection |
126612352 | 12661235 | 3 | Diabetes mellitus |
126612352 | 12661235 | 4 | Diabetes mellitus |
126612352 | 12661235 | 5 | Blood cholesterol increased |
126612352 | 12661235 | 6 | Blood cholesterol increased |
126612352 | 12661235 | 7 | Anxiety |
126612352 | 12661235 | 8 | Anxiety |
126612352 | 12661235 | 9 | Hypertension |
126612352 | 12661235 | 10 | Hypertension |
126612352 | 12661235 | 12 | Hypertension |
126612352 | 12661235 | 13 | Insomnia |
126612352 | 12661235 | 14 | Asthma |
126612352 | 12661235 | 15 | Abdominal discomfort |
126612352 | 12661235 | 20 | Urinary tract infection |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126612352 | 12661235 | Abdominal discomfort | |
126612352 | 12661235 | Blood pressure increased | |
126612352 | 12661235 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126612352 | 12661235 | 1 | 20160506 | 20160510 | 0 | |
126612352 | 12661235 | 2 | 20160509 | 0 |